NHS England has published a consultation document which sets out proposals for updating the NHS Commercial Framework for New Medicines. The BIA has responded to the consultation on updating the NHS commercial framework for new medicines.
The BIA has responded to the consultation on the Budget Impact Test (BIT) threshold. We welcome the proposal to increase the BIT threshold as this will help to ensure timely patient access to innovative medicines.
The BIA has responded to the HM Treasury, Department for Work and Pensions, and Ministry of Housing, Communities and Local Government's consultation on the Pension Investment Review.
Our submission urges caution and careful consideration of the impacts on life sciences as the government determines how to move forward with the taxation of capital gains.
We call for stability and the retention of already established commitments and programmes including R&D tax relief, pensions reform, and various other funding mechanisms such as the UKRI and Innovate UK budgets.
Life Sciences Investment Envoy Dr Dan Mahony responds to the Department for Business and Trade’s consultation on its Long-term Investment for Technology and Science (LIFTS) initiative
